Ewa Krzystanek

542 total citations
49 papers, 300 citations indexed

About

Ewa Krzystanek is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Ewa Krzystanek has authored 49 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 11 papers in Psychiatry and Mental health. Recurrent topics in Ewa Krzystanek's work include Multiple Sclerosis Research Studies (16 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Peripheral Neuropathies and Disorders (4 papers). Ewa Krzystanek is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Peripheral Neuropathies and Disorders (4 papers). Ewa Krzystanek collaborates with scholars based in Poland, United States and Switzerland. Ewa Krzystanek's co-authors include Marek Krzystanek, Artur Pałasz, Joanna Siuda, Andrzej Knapik, Grzegorz Opala, Henryk I. Trzeciak, Agnieszka Gorzkowska, Anna Brzęk, Ryszard Wiaderkiewicz and Maciej Świat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Ewa Krzystanek

46 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Krzystanek Poland 10 80 77 56 51 45 49 300
Maged Abdel Naseer Egypt 11 84 1.1× 45 0.6× 34 0.6× 36 0.7× 46 1.0× 28 282
Charly Keytsman Belgium 13 173 2.2× 43 0.6× 65 1.2× 51 1.0× 20 0.4× 27 377
Aysel Milanlıoğlu Türkiye 9 38 0.5× 53 0.7× 40 0.7× 19 0.4× 47 1.0× 32 251
Odinak Mm Russia 11 50 0.6× 160 2.1× 36 0.6× 67 1.3× 50 1.1× 88 399
Dürdane Aksoy Türkiye 10 46 0.6× 64 0.8× 41 0.7× 92 1.8× 44 1.0× 41 334
Gönül Vural Türkiye 11 64 0.8× 54 0.7× 51 0.9× 52 1.0× 22 0.5× 36 296
Alicia Zha United States 13 30 0.4× 69 0.9× 35 0.6× 26 0.5× 99 2.2× 33 421
Salvatore Iacono Italy 10 39 0.5× 125 1.6× 40 0.7× 42 0.8× 18 0.4× 35 338
Meredith Barad United States 10 87 1.1× 80 1.0× 108 1.9× 107 2.1× 11 0.2× 26 348
K. Heerlein Germany 9 37 0.5× 134 1.7× 16 0.3× 31 0.6× 131 2.9× 15 383

Countries citing papers authored by Ewa Krzystanek

Since Specialization
Citations

This map shows the geographic impact of Ewa Krzystanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Krzystanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Krzystanek more than expected).

Fields of papers citing papers by Ewa Krzystanek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Krzystanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Krzystanek. The network helps show where Ewa Krzystanek may publish in the future.

Co-authorship network of co-authors of Ewa Krzystanek

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Krzystanek. A scholar is included among the top collaborators of Ewa Krzystanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Krzystanek. Ewa Krzystanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jędrzejowska–Szypułka, Halina, et al.. (2025). Does Systematic Use of Small Doses of Vitamin D Have Anti-Inflammatory Effects and Effectively Correct Deficiency Among Healthy Adults?. Nutrients. 17(2). 352–352. 2 indexed citations
2.
Krzystanek, Ewa, et al.. (2024). Insomnia, Fatigue, Bladder Disorders and Mood Disorders among Polish Patients with Multiple Sclerosis: Cross-Sectional Study. Journal of Clinical Medicine. 13(4). 1043–1043. 5 indexed citations
3.
Lasek‐Bal, Anetta, et al.. (2024). Exploring Sleep Architecture in Polish Patients with Multiple Sclerosis: A Polysomnography Study. Brain Sciences. 14(9). 932–932.
4.
Newsome, Scott D., Ewa Krzystanek, Krzysztof Selmaj, et al.. (2024). OCARINA II, Phase III Study: Results of Subcutaneous Ocrelizumab Administration in Patients with Multiple Sclerosis (S31.006). Neurology. 102(7_supplement_1). 5 indexed citations
5.
6.
Lasek‐Bal, Anetta, et al.. (2023). Epileptiform activity in the acute phase of stroke predicts the outcomes in patients without seizures. Frontiers in Neurology. 14. 1096876–1096876. 1 indexed citations
7.
Krzystanek, Ewa, et al.. (2022). Selected neurological complications of oncological treatment — literature overview. Oncology in Clinical Practice. 19(5). 346–355.
8.
Jamróz-Wiśniewska, Anna, Radosław Zajdel, Agnieszka Słowik, et al.. (2021). Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients. Journal of Clinical Medicine. 10(9). 1830–1830. 7 indexed citations
9.
10.
11.
Krzystanek, Ewa, et al.. (2020). Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients. Medicina. 56(12). 726–726. 18 indexed citations
12.
Krzystanek, Ewa, et al.. (2020). Adequate Knowledge of Stroke Symptoms, Risk Factors, and Necessary Actions in the General Population of Southern Poland. Brain Sciences. 10(12). 1009–1009. 16 indexed citations
13.
Łabuz-Roszak, Beata, Ewa Niewiadomska, K Kubicka, et al.. (2019). Multiple sclerosis: oral health, behaviours and limitations of daily oral hygiene — a questionnaire study. Neurologia i Neurochirurgia Polska. 53(4). 271–276. 4 indexed citations
14.
Krzystanek, Ewa & Przemysława Jarosz‐Chobot. (2018). Dimethyl fumarate in a patient with multiple sclerosis and type 1 diabetes mellitus: The importance of ketonuria. Multiple Sclerosis and Related Disorders. 21. 42–45. 4 indexed citations
15.
Drzazga, Z., et al.. (2018). Use of MRI to Measure Whole Brain Atrophy in MS Patients. Acta Physica Polonica A. 133(3). 725–727. 1 indexed citations
16.
Krzystanek, Ewa, et al.. (2017). Dysphagia due to brain stroke – diagnostic and therapeutic guidelines. SHILAP Revista de lepidopterología. 17(4). 208–212. 2 indexed citations
17.
Ciułkowicz, Marta, et al.. (2017). Depression, sleep disturbances and anxiety in patients with relapsing-remitting multiple sclerosis: a longitudinal cohort observation.. PubMed. 29(Suppl 3). 464–468. 12 indexed citations
18.
Krzystanek, Marek, Ewa Krzystanek, Henryk I. Trzeciak, et al.. (2013). Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain. Pharmacological Reports. 65(3). 724–729. 2 indexed citations
19.
Krzystanek, Ewa, Marek Krzystanek, Grzegorz Opala, et al.. (2007). Platelet phospholipase A2 activity in patients with Alzheimer’s disease, vascular dementia and ischemic stroke. Journal of Neural Transmission. 114(8). 1033–1039. 18 indexed citations
20.
Krzystanek, Ewa, et al.. (1999). Structure of New Imidazoline Derivatives and Their Cardiovascular Effect in Ratsa. Annals of the New York Academy of Sciences. 881(1). 106–109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maged Abdel Naseer Breakdown of academic impact, for papers by Charly Keytsman Breakdown of academic impact, for papers by Aysel Milanlıoğlu Breakdown of academic impact, for papers by Odinak Mm Breakdown of academic impact, for papers by Dürdane Aksoy Breakdown of academic impact, for papers by Gönül Vural Breakdown of academic impact, for papers by Alicia Zha Breakdown of academic impact, for papers by Salvatore Iacono Breakdown of academic impact, for papers by Meredith Barad Breakdown of academic impact, for papers by K. Heerlein
Rankless by CCL
2026